FRM
BLFS icon

Fox Run Management’s BioLife Solutions BLFS Stock Holding History

Fox Run Management’s Portfolio BLFS Stock Details BLFS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.04M Buy
+36,709
New +$858K 0.17% 171
2025
Q4 		– Sell
-9,504
Closed -$242K – 929
2025
Q3 		$242K Buy
+9,504
New +$225K 0.04% 751

Other funds holding BLFS

T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
CC
Casdin Capital New York $2B AUM 147.21% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
FAM
Fred Alger Management New York $30B AUM 76.99% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Fox Run Management's BLFS Position: Q2 2026 in Review

Fox Run Management opened a new position in BioLife Solutions (BLFS) in Q2 2026: 36,709 shares worth $1.04M. The stake represents 0.17% of the portfolio and ranks #171 among its holdings. This is a return to the name: Fox Run Management previously reported a position in BLFS as recently as Q3 2025.

Fox Run Management first reported a position in BLFS in Q3 2025 and has held it in 2 quarters since. 216 funds tracked by Wall St. Rank hold BLFS as of Q2 2026.

  • Fox Run Management held 36,709 shares of BioLife Solutions worth $1.04M as of Q2 2026.
  • BioLife Solutions was a new Fox Run Management position in Q2 2026.
  • BioLife Solutions made up 0.17% of Fox Run Management's portfolio in Q2 2026, its #171 holding.
  • Fox Run Management first reported a position in BioLife Solutions in Q3 2025 and has held it in 2 quarters since.
  • 216 funds tracked by Wall St. Rank held BioLife Solutions as of Q2 2026.

Based on Fox Run Management's 13F filing for Q2 2026, filed 4 Aug 2026.